Impax Laboratories Inc. v. Lannett Holdings Inc.

U.S. Court of Appeals for the Federal Circuit July 2, 2018

Opinion

United States Court of Appeals for the Federal Circuit ______________________

July 2, 2018

Appeal No. 2017-2020

IMPAX LABORATORIES INC., ASTRAZENECA AB, ASTRAZENECA UK LIMITED, Plaintiffs-Appellees

LANNETT HOLDINGS INC., LANNETT COMPANY INC., Defendants-Appellants ______________________

Decided: June 28, 2018 Precedential Opinion ______________________

Please make the following change: On page 2, line 7, U.S. Patent 6,760,237 is changed to U.S. Patent 6,750,237.